107
Participants
Start Date
December 22, 2022
Primary Completion Date
May 5, 2025
Study Completion Date
May 5, 2025
Trimodulin
IMP will be administered via IV infusion on 5 consecutive days
Placebo (human albumin 1%)
IMP will be administered via IV infusion on 5 consecutive days
Investigational Site #4304, Vienna
Investigational Site #3201, Ottignies
Investigational Site #5401, Buenos Aires
Investigational Site #2702, Klerksdorp
Investigational Site #3203, Edegem
Investigational Site #3202, Mechelen
Investigational Site #4302, Linz
Investigational SIte #3603, Debrecen
Investigational Site #5403, Córdoba
Investigational Site #2703, Mthatha
Investigational Site #2705, Plettenberg Bay
Investigational Site #3601, Szeged
Investigational site #2706, Kimberley
Investigational Site #4303, Klagenfurt
Investigational Site #4904, Berlin
Investigational Site #3403, Madrid
Investigational Site #3404, Madrona
Investigational Site #4903, Hanover
Investigational Site #9004, Istanbul
Investigational Site #3305, Saint-Etienne
Investigational Site #4901, Bochum
Investigational Site #7002, Kaunas
Investigational Site #9001, Trabzon
Investigational Site #3306, Strasbourg
Investigational Site #3308, Strasbourg
Investigational Site #3304, Paris
Investigational Site #3301, Paris
Investigational Site #3303, Melun
Investigational Site #3307, Salouël
Investigational Site #4907, München
Investigational Site #2102, Malacky
Investigational Site #3302, Trévenans
Investigational Site #2101, Nitra
Investigational Site #2103, Banská Bystrica
Investigational Site #5402, Córdoba
Investigational Site #5508, Campo Largo
Investigational Site #5509, Ribeirão Preto
Investigational Site #5511, São Paulo
Investigational Site #5505, Botucatu
Investigational Site #5503, Porto Alegre
Investigational Site #5507, Porto Alegre
Investigational Site #5506, Porto Alegre
Investigational Site #5502, Santo André
Investigational Site #5510, Santos
Investigational Site #5504, São José do Rio Preto
Investigational Site #5501, São Paulo
Investogational Site #4902, Cottbus
Investigational Site #7102, Daugavpils
Investigational Site #7101, Riga
Investigational Site #7007, Kaunas
Investigational Site #7005, Kaunas
Investigational Site #7003, Klaipėda
Investigational Site #7004, Šiauliai
Investigational Site #7006, Vilnius
Investigational Site #7001, Vilnius
Investigational Site #3502, Guimarães
Investogational SIte #3501, Lisbon
Investigational Site #2105, Michalovce
Investigational Site #2104, Svidník
Investigational Site #2701, Pretoria
Investigational Site #2707, Pretoria
Investigational Site #2704, Pretoria
Investigational Site #3401, Barcelona
Investigational Site #9005, Ankara
Lead Sponsor
Biotest
INDUSTRY